BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25245783)

  • 1. Perturbation of fluid dynamics properties of water molecules during G protein-coupled receptor-ligand recognition: the human A2A adenosine receptor as a key study.
    Sabbadin D; Ciancetta A; Moro S
    J Chem Inf Model; 2014 Oct; 54(10):2846-55. PubMed ID: 25245783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bridging molecular docking to membrane molecular dynamics to investigate GPCR-ligand recognition: the human A₂A adenosine receptor as a key study.
    Sabbadin D; Ciancetta A; Moro S
    J Chem Inf Model; 2014 Jan; 54(1):169-83. PubMed ID: 24359090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example.
    Zeng L; Guan M; Jin H; Liu Z; Zhang L
    Chem Biol Drug Des; 2015 Dec; 86(6):1438-50. PubMed ID: 26072970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Water network perturbation in ligand binding: adenosine A(2A) antagonists as a case study.
    Bortolato A; Tehan BG; Bodnarchuk MS; Essex JW; Mason JS
    J Chem Inf Model; 2013 Jul; 53(7):1700-13. PubMed ID: 23725291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor.
    Chen D; Ranganathan A; IJzerman AP; Siegal G; Carlsson J
    J Chem Inf Model; 2013 Oct; 53(10):2701-14. PubMed ID: 23971943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selecting an optimal number of binding site waters to improve virtual screening enrichments against the adenosine A2A receptor.
    Lenselink EB; Beuming T; Sherman W; van Vlijmen HW; IJzerman AP
    J Chem Inf Model; 2014 Jun; 54(6):1737-46. PubMed ID: 24835542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel approaches for targeting the adenosine A2A receptor.
    Yuan G; Gedeon NG; Jankins TC; Jones GB
    Expert Opin Drug Discov; 2015 Jan; 10(1):63-80. PubMed ID: 25311639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel adenosine A(2A) receptor ligands: a synthetic, functional and computational investigation of selected literature adenosine A(2A) receptor antagonists for extending into extracellular space.
    Jörg M; Shonberg J; Mak FS; Miller ND; Yuriev E; Scammells PJ; Capuano B
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3427-33. PubMed ID: 23602401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and energetic effects of A2A adenosine receptor mutations on agonist and antagonist binding.
    Keränen H; Gutiérrez-de-Terán H; Åqvist J
    PLoS One; 2014; 9(10):e108492. PubMed ID: 25285959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling of adenosine receptors.
    Martinelli A; Ortore G
    Methods Enzymol; 2013; 522():37-59. PubMed ID: 23374179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of the conformational dynamics of the adenosine A2A receptor by means of molecular dynamics simulation].
    Novikov GV; Sivozhelezov VS; Shaĭtan KV
    Biofizika; 2013; 58(4):618-34. PubMed ID: 24455882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing Hydration Patterns in Class-A GPCRs via Biased MD: The A
    Zia SR; Gaspari R; Decherchi S; Rocchia W
    J Chem Theory Comput; 2016 Dec; 12(12):6049-6061. PubMed ID: 27951680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative quality assessment strategy to compare performances of GPCR-ligand docking protocols: the human adenosine A(2A) receptor as a case study.
    Ciancetta A; Cuzzolin A; Moro S
    J Chem Inf Model; 2014 Aug; 54(8):2243-54. PubMed ID: 25046649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor.
    Guo D; Pan AC; Dror RO; Mocking T; Liu R; Heitman LH; Shaw DE; IJzerman AP
    Mol Pharmacol; 2016 May; 89(5):485-91. PubMed ID: 26873858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding kinetics of ZM241385 derivatives at the human adenosine A2A receptor.
    Guo D; Xia L; van Veldhoven JP; Hazeu M; Mocking T; Brussee J; Ijzerman AP; Heitman LH
    ChemMedChem; 2014 Apr; 9(4):752-61. PubMed ID: 24591302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the adenosine A
    Sun B; Bachhawat P; Chu ML; Wood M; Ceska T; Sands ZA; Mercier J; Lebon F; Kobilka TS; Kobilka BK
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2066-2071. PubMed ID: 28167788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength.
    Segala E; Guo D; Cheng RK; Bortolato A; Deflorian F; Doré AS; Errey JC; Heitman LH; IJzerman AP; Marshall FH; Cooke RM
    J Med Chem; 2016 Jul; 59(13):6470-9. PubMed ID: 27312113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.
    Jaakola VP; Griffith MT; Hanson MA; Cherezov V; Chien EY; Lane JR; Ijzerman AP; Stevens RC
    Science; 2008 Nov; 322(5905):1211-7. PubMed ID: 18832607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultraslow Water-Mediated Transmembrane Interactions Regulate the Activation of A2A Adenosine Receptor.
    Lee Y; Kim S; Choi S; Hyeon C
    Biophys J; 2016 Sep; 111(6):1180-1191. PubMed ID: 27653477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substructure-based virtual screening for adenosine A2A receptor ligands.
    van der Horst E; van der Pijl R; Mulder-Krieger T; Bender A; Ijzerman AP
    ChemMedChem; 2011 Dec; 6(12):2302-11. PubMed ID: 22021213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.